Xcell Biosciences

Xcell has developed a technology to capture and culture cancer and other primary cells from blood and solid tissue for use as a new research and discovery tool.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Francisco, CA, US
  • Currency USD
  • Founded June 2012
  • Employees 5
  • Website xcellbio.com

Company Summary

Xcell Biosciences is democratizing primary cell culture through an integrated set of products combining specialized substrates, media, and protocols, with a proprietary growth chamber as a new research and drug discovery technology for cancer and other primary cell types. As a key application, this technology for the first time provides researchers and clinicians with an abundant source of patient-derived cancer cells, directly from patient blood


  • Chief Executive Officer

    Brian is an experienced business professional educated as a molecular biologists. He formerly worked as a business strategy life sciences consultant at L.E.K. Consulting and in private equity at Strategyn Equity Partners. He was most recently with Novartis Pharma, and has degrees from Purdue University, Keck Graduate Institute of Applied Life Sciences, University of California, Berkeley.

  • Chief Scientific Officer

    James is an experienced cancer biologist and imaging expert in high resolution fluorescence microscopy – most recently a research scientist at Lawrence Berkeley National Lab. Prior to LBL, James was a researcher at Harvard Medical School, where he characterized circulating tumor cells (CTCs).

  • Chief Technology Officer

    The technology’s computer vision algorithms for high content screening applications are under development by Craig Yoshioka, PhD, who has extensive experience in hardware automation and image analysis software development. Craig joins us as a scientist with start-up industry experience and a doctorate from The Scripps Research Institute.


Previous Investors

  • Steve Blank
    Jim Hornthal
  • Wilson Sonsini Goodrich & Rosati

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free